{"name":"InnaVirVax","slug":"innavirvax","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQUmZGcDdXbmNOdjlJUERXMk5tYUJaT3dtM2JEd3hHWFJDV21OS2xLN1BUcHIxRFhNTEJHd20td1lXMDNyUUYtdTQtZHhBOWNkRVJ5VW8xZlVuZll5RDNFTmJBbWcyZjZmMUZqcEVVM2xJV1pyLVZMSzJxRkZINVFFdG56SzJZbVFiLVJQdGZBNXZXN0d1N0tqTHVKdXpFYmNRRTlXV1Z2Z0Y?oc=5","date":"2012-06-29","type":"pipeline","source":"News-Medical","summary":"HIV therapy: Interview with Joël Crouzet, CEO of InnaVirVax - News-Medical","headline":"HIV therapy: Interview with Joël Crouzet, CEO of InnaVirVax - News","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}